Contract facts
NONENo full NAICS 541714 intel page yet. Browse NAICS intelligence
IN VITRO AND IN VIVO ASSESSMENT OF BUPRENORPHINE EXTENDED RELEASE INJECTIONS FOR GENERIC PRODUCT EQUIVALENCE is a federal NONE award for Fda Office Of Acq Grant Svcs held by Virginia Commonwealth University. Estimated value $876K ($876K obligated). Current period of performance ends Sep 29, 2026. Last award drew 1 bidder. Place of performance: RICHMOND VA. Related solicitation FDABAA-23-0123.
IN VITRO AND IN VIVO ASSESSMENT OF BUPRENORPHINE EXTENDED RELEASE INJECTIONS FOR GENERIC PRODUCT EQUIVALENCE
Recompete timing
PublicCurrent PoP ends Sep 29, 2026 (39 days remaining). Agencies typically plan 12–18 months ahead — at 1.3 months out, that window is already open. The buying decision is likely already in motion.
Incumbent footprint
Public recordVirginia Commonwealth University — $39.3M obligated across 21 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).
Related awards
Same incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 75F40123C00196?
75F40123C00196 (VITRO and in VIVO assessment of) is a Fda Office Of Acq Grant Svcs award with a potential value of $876K, currently held by Virginia Commonwealth University. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 75F40123C00196?
Fda Office Of Acq Grant Svcs awarded 75F40123C00196 to Virginia Commonwealth University (potential $876K).
Who is the incumbent on 75F40123C00196?
Virginia Commonwealth University is the incumbent with $39.3M across 21 related awards in SCOUT’s public footprint. The current period of performance ends Sep 29, 2026.
When does Virginia Commonwealth University’s 75F40123C00196 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 29, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.